Komori
Other Disclosures4896K Pharma,Inc.Pharmaceuticals

Notice Regarding the Launch of an English-Language IR Website and Official Social Media Accounts (X and note)

K Pharma,Inc. launched an English-language IR website for overseas investors and began operating X and note as its official social media accounts.

Worth reading
43Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Definitive
How definitive the wording is.

Announced details

English-language IR websiteOfficial X accountOfficial note account
Applicable field (uses covered by this announcement)

IR information, financial results, research and development, business initiatives, and IR event information

Launch dateEnglish-language IR website: 13 November 2026 (launch; actual); official social media accounts (X and note): November 2026 (launch; actual)

In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.

Announced details
ItemDetails
Names of Products / Services CoveredEnglish-language IR website, Official X account, Official note account
Launch dateEnglish-language IR website: 13 November 2026 (launch; actual); official social media accounts (X and note): November 2026 (launch; actual)
Applicable areaIR information, financial results, research and development, business initiatives, and IR event information
Items this document does not state (15)
CounterpartyCounterparty overviewRelationship with the CompanyContract ValueOffering priceContract DateAward/certification nameAwarding / certifying bodyRegistration number and expiry dateLocationLocation scaleQuantitative EffectsUsage historyImpact on Business PerformanceSource

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To provide overseas investors with information on the business and disclosure materials in English, deepen the understanding of financial results and the business among stakeholders including shareholders and investors, and make information more accessible.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.